Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Monoclonal Gammopathy of Undetermined Significance × Urination × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Smoldering Multiple Myeloma 1 Salivary Gland Adenoma, Pleomorphic 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Monoclonal Gammopathy of Undetermined Significance 1 Liver Cirrhosis 1 Hematologic Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Curcumin 2 Urination 1 Probiotics 1 Metformin 1 Docosahexaenoic Acids 1 Diet, Plant-Based 1 Diet, Mediterranean 1 Biopsy 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03951220 2025-08-19

LOOMIS

Oxford University Hospitals NHS Trust

67 enrolled 24 charts

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡